6 results
10-K
2021 FY
EX-10.20
GLUE
Monte Rosa Therapeutics Inc
29 Mar 22
Annual report
4:15pm
health crisis); shortages of materials and supply chain disruptions (which shortages and disruptions are not unique to the party claiming Force Majeure
8-K
EX-99.1
GLUE
Monte Rosa Therapeutics Inc
12 Nov 21
Monte Rosa Therapeutics Announces First Development Candidate and Reports Third Quarter 2021 Financial Results and Business Updates
12:00am
, supply chain, and operations, as well as those risks and uncertainties set
forth in its registration statement on form S-1 filed, the quarterly report
8-K
EX-99.1
jgol2g z9s7q5fy3heo
12 Aug 21
Monte Rosa Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
8:31am
- Prev
- 1
- Next